Last reviewed 2026-04-23 · How we verify

Layla Tab.

Layla Tab is a combination of two medications, a calcium channel blocker and a beta blocker, which work together to lower blood pressure and reduce the workload on the heart.

Layla Tab is a combination of two medications, a calcium channel blocker and a beta blocker, which work together to lower blood pressure and reduce the workload on the heart. Used for Hypertension, Angina pectoris.

At a glance

Mechanism of action

The calcium channel blocker component, verapamil, works by relaxing the muscles in the heart and blood vessels, allowing blood to flow more easily and reducing blood pressure. The beta blocker component, atenolol, works by blocking the effects of the hormone epinephrine, also known as adrenaline, which can increase heart rate and blood pressure. By combining these two mechanisms, Layla Tab is able to provide effective blood pressure control and reduce the risk of heart-related complications.

Approved indications

• Hypertension
• Angina pectoris

Common side effects

• Edema
• Dizziness
• Fatigue
• Headache
• Nausea

Key clinical trials

• Phase 4 Study of Laybon Tab. in Knee Osteoarthritis (PHASE4)
• To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee (PHASE4)
• To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Layla Tab. CI brief — competitive landscape report
• Layla Tab. updates RSS · CI watch RSS
• Mather's Pharm. Co., Ltd. portfolio CI